| Literature DB >> 35889677 |
Nikola Gligorijević1, Tatjana Mihajlov-Krstev2, Milena Kostić1, Ljubiša Nikolić3, Nemanja Stanković4, Vesna Nikolić3, Ana Dinić3, Marko Igić1, Nirit Bernstein5.
Abstract
The surface quality of denture base resins allows for easy colonization by microorganisms including Candida albicans and Staphylococcus aureus, which cause major diseases of the oral cavity such as denture stomatitis. The widespread use of silver nanoparticles (AgNPs) in various fields of medicine has led to research of their possible application in dentistry, mostly in the prevention of bacterial adhesion, proliferation, and biofilm formation. The aim of the study was to synthesize cold and heat-curing denture base resins modified with AgNPs and AgCl, and evaluate the potential of the modified resins to reduce the growth of C. albicans and S.aureus. The produced material was characterized by Fourier transform infrared spectroscopy (FTIR). The antimicrobial potential of the modified material was demonstrated by the disc-diffusion method, microdilution method, and a modified microdilution method (i.e., disk-diffusion method in broth with viable counting). Spectroscopy confirmed the incorporation of biocidal materials into the structure of the denture base resins. The AgCl and AgNPs modified resins showed an antimicrobial effect. The significance of the study is in the potential therapeutic effects of the modified materials for prevention and threating staphylococci and candida in elderly patients, who are in most cases denture wearers and have a greater susceptibility to develop opportunistic infections. Modified denture base resins can significantly reduce the presence of infection at the point of contact between the denture and the mucous membrane of the prosthetic restoration. Biological tests of modified denture base resins will follow.Entities:
Keywords: AgNPs; antimicrobial effect; denture base resins; silver nanoparticles
Year: 2022 PMID: 35889677 PMCID: PMC9317501 DOI: 10.3390/nano12142453
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.719
Figure 1FTIR spectra of: MMA monomers (a), cold-curing PMMA polymers (b), and polymerized mixtures of monomers and cold-curing PMMA polymers (c).
Figure 2Structure of the MMA monomers (a) and the PMMA polymers (b).
Figure 3FTIR spectra of polymerized PMMA cold-curing (a), polymerized 10% AgNPs PMMA cold-curing (b), and (c) polymerized 10% AgCl PMMA cold-curing (c).
Figure 4FTIR spectra of the polymerized heat-curing PMMA (a), the polymerized heat-curing 10% AgNPs PMMA (b), and the polymerized heat-curing 10% AgCl PMMA (c).
Figure 5(a) SEM image of cold-curing PMMA with 10.0 wt% of AgNPs (1500×, bar 10 µm). (b) SEM image of cold-curing PMMA with 10.0 wt% of AgCl (500×, bar 10 µm).
Antimicrobial activity of samples against S. aureues and C. albicans strains tested by the disk-diffusion antibiotic sensitivity method. Zones of inhibition are expressed in mm. The results are averages ± S.E. (n = 3).
| Sample | ||
|---|---|---|
| PMMA cold-curing | 0.0000 ± 0.0000 | 0.0000 ± 0.0000 |
| PMMA heat- curing | 0.0000 ± 0.0000 | 0.0000 ± 0.0000 |
| 2% AgNPs PMMA cold-curing | 0.0400 ± 0.0306 | 0.0200 ± 0.0058 |
| 2% AgNPs PMMA heat-curing | 0.0400 ± 0.0306 | 0.0200 ± 0.0058 |
| 5% AgNPs PMMA cold-curing | 0.0133 ± 0.0088 | 0.0300 ± 0.0058 |
| 5% AgNPs PMMA heat-curing | 0.0077 ± 0.0062 | 0.0200 ± 0.0058 |
| 10% AgNPs PMMA cold-curing | 9.0667 ± 0.0882 *** | 9.0300 ± 0.1234 ** |
| 10% AgNPs PMMA heat-curing | 9.0367 ± 0.0426 *** | 9.0200 ± 0.0945 *** |
| 10% AgCl PMMA cold-curing | 9.0233 ± 0.0962 *** | 9.0033 ± 0.2114 ** |
| 10% AgCl PMMA heat-curing | 9.0033 ± 0.0561 *** | 9.0667 ± 0.1348 *** |
| ANOVA (F, significance) | 9046.24; | 2486.63; |
** p < 0.01, *** p < 0.001 based on Dunnett T3 Post-Hoc test (vs. both cold and heat-curing samples of PMMA and lower concentrations of AgNPs PMMA).
Antimicrobial activity of samples against S. aureus and C. albicans strains tested by microdilution method (MIC/MMC). Minimum inhibitory concentrations (MIC) and minimum microbicidal concentrations (MMC) were determined with three independent repetitions.
| Sample | ||
|---|---|---|
| MIC/MMC, mg/mL | ||
| 10% AgNPs PMMA cold curing | 12.50/12.50 | 12.50/12.50 |
| 10% AgNPs PMMA hot curing | 12.50/12.50 | 12.50/12.50 |
| 10% AgCl PMMA cold curing | 3.13/6.25 | 3.13/3.13 |
| 10% AgCl PMMA hot curing | 3.13/6.25 | 3.13/3.13 |
Antimicrobial activity of samples against S. aureus and C. albicans strains tested using by a modified microdilution method (a broth disk-diffusion method in broth with viable counting) (log-CFU/mL). The values are averages and SE (n = 3). Different letters near the means represent significant differences by Dunnett T3 test.
| Sample | ||
|---|---|---|
| Cell Count × 106 | ||
| Growth Control | 99.667 ± 0.882 | 99.667 ± 0.882 |
| PMMA cold-curing | 100.000 ± 0.000 | 101.000 ± 1.528 |
| PMMA heat-curing | 100.000 ± 0.000 | 100.667 ± 1.764 |
| 2% AgNPs PMMA cold-curing | 100.000 ± 0.000 | 5.433 ± 0.260 a *** bc ** |
| 2% AgNPs PMMA heat-curing | 100.000 ± 0.000 | 2.000 ± 0.012 a *** bc ** |
| 5% AgNPs PMMA cold-curing | 0.133 ± 0.005 abc *** | 0.001 ± 0.000 a *** bc ** |
| 5% AgNPs PMMA heat-curing | 0.306 ± 0.005 abc *** | 0.000 ± 0.000 a *** bc ** |
| 10% AgNPs PMMA cold-curing | 0.000 ± 0.000 abc *** | 0.000 ± 0.000 a *** bc ** |
| 10% AgNPs PMMA heat-curing | 0.000 ± 0.000 abc *** | 0.000 ± 0.000 a *** bc ** |
| 10% AgCl PMMA cold-curing | 3.847 ± 0.144 abc *** | 1.700 ± 0.115 a *** bc ** |
| 10% AgCl PMMA heat-curing | 0.281 ± 0.012 abc *** | 0.000 ± 0.000 a *** bc ** |
| ANOVA (F. significance) | 36,952.25; | 3759.21; |
**—p < 0.01, ***—p < 0.001 (Dunnett T3 Post Hoc test); (a—vs. Growth Control, b—vs. PMMA cold-curing, c—vs. PMMA heat-curing).